| Trial registration number
|
NCT04685447 |
Full text link
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04685447
|
First author
Last imported at : May 19, 2022, 8:39 a.m.
Source : ClinicalTrials.gov
|
Francesca Viazzi
|
Contact
Last imported at : May 19, 2022, 8:39 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Dec. 31, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2020-12-28
|
Recruitment status
Last imported at : May 19, 2022, 8:39 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
multi-center
|
Study aim
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- patients undergoing maintenance hemodialysis
- confirmed severe acute respiratory syndrome-coronavirus2 infection
|
Exclusion criteria
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
- acute kidney injury
|
Number of arms
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Universita degli Studi di Genova
|
Inclusion age min
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Italy
|
Type of patients
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
30
|
primary outcome
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Longitudinal changes of interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), and interferon-gamma (IFN-γ) plasma levels during Covid19 in hemodialysis patients;Longitudinal changes of soluble TLR4 (sTLR4) plasma levels during Covid19 in hemodialysis patients
|
Notes
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 495, "treatment_name": "Hemodialysis", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1033, "treatment_name": "Protein-leaking hemodialysis", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}]
|